Determination of five di-(2-ethylhexyl)phthalate metabolites in urine by UPLC-MS/MS, markers of blood transfusion misuse in sports

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 908, Issue , 2012, Pages 113-121

  Monfort, Núria ^a,b   Ventura, Rosa ^a,b   Balcells, Georgina ^a   Segura, Jordi ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Blood doping; Di (2 ethylhexyl)phthalate (DEHP); Doping control; Plasticizers; Transfusion; Ultraperformance liquid chromatography coupled to tandem mass spectrometry (UPLC MS MS)

Indexed keywords

ACIDIC EXTRACTION; BLOOD TRANSFUSION; CONTROL GROUPS; DI-2-ETHYLHEXYL PHTHALATE; DOPING CONTROL; ETHYL ACETATES; EXTRACTION RECOVERY; GLUCURONIDASE; GRADIENT ELUTION; INTER-ASSAY PRECISION; INTERNAL STANDARDS; LIMITS OF QUANTITATIONS; MOBILE PHASE; MONO-(2-ETHYLHEXYL)PHTHALATE; MULTIPLE REACTION MONITORING; PHTHALATES; RUNTIMES; THRESHOLD CONCENTRATIONS; TRANSFUSION; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY; UPLC-MS/MS;

ACETONITRILE; BIOMOLECULES; DEIONIZED WATER; ELECTROSPRAY IONIZATION; ENZYMATIC HYDROLYSIS; ESCHERICHIA COLI; ESTERS; FORMIC ACID; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PLASTICIZERS; REINFORCED PLASTICS; SOLVENTS;

BLOOD;

ACETIC ACID ETHYL ESTER; ACETONITRILE; ANION; BETA GLUCURONIDASE; FORMIC ACID; MONO (2 CARBOXYMETHYLHEXYL)PHTHALATE; MONO (2 ETHYL 5 CARBOXYPENTYL)PHTHALATE; MONO (2 ETHYL 5 HYDROXYHEXYL)PHTHALATE; MONO (2 ETHYL 5 OXOHEXYL)PHTHALATE; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; BLOOD TRANSFUSION; ELECTROSPRAY; ESCHERICHIA COLI; FEMALE; FLOW RATE; HUMAN; HYDROLYSIS; ISOTOPE LABELING; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ERROR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ADULT; BLOOD TRANSFUSION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLHEXYL PHTHALATE; DOPING IN SPORTS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

ESCHERICHIA COLI;

EID: 84868303680     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.09.030     Document Type: Article

References (45)

1. European Commission Opinion on Medical Devices Containing DEHP plasticised PVC; Neonates and Other Groups Possibly at Risk from DEHP Toxicity 2002, Scientific Committee on Medicinal Products and Medical Devices (SCMPMD), Brussels, Available at: http://ec.europa.eu/food/fs/sc/scmp/out43_en.pdf (accessed June 2012).
2. FDA Public Health Notification, PVC Devices Containing Plasticizer DEHP, US Food and Drug Administration, Center of Devices and Radiological Health, Available at: (accessed June 2012). http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062182.htm.
3. Horowitz B., Stryker M.H., Waldman A.A., Woods K.R., Gass J.D. J. Drago. Vox Sanquinis. 1985, 48:150-155.
4. Simmchen J., Ventura R., Segura J. Transfus. Med. Rev. 2012, 26:27-37.
5. Koch H.M., Calafat A.M. Philos. Trans. R. Soc. B 2009, 364:2063-2078.
6. Frederiksen H., Skakkebæk N., Andersson A. Mol. Nutr. Food Res. 2007, 51:899-911.
7. Fromme H., Bolte G., Koch H.M., Angerer J., Boehmer S., Drexler H., Mayer R., Liebl Int B. J. Hyg. Environ. Health 2007, 210:21-33.
8. Lottrup G., Anderson A.M., Leffers H., Mortensen G.K., Toppari J., Skakkebæk N.E., Main K.M. Int. J. Androl. 2006, 29:172-180.
9. Blystone C.R., Kissling G.E., Bishop J.B., Chapin R.E., Wolfe G.W., Foster P.M.D. Toxicol. Sci. 2010, 116:640-646.
10. Latini G., Verrotti A., De Felice C. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004, 4(1):37-40.
11. Koch H.M., Preuss R., Angerer J. Int. J. Androl. 2006, 29:155-165.
12. Albro P.W., Lavenhar S.R. Drug Metab. Rev. 1989, 21:13-34.
13. Silva M.J., Barr D.B., Reidy J.A., Kato K., Malek N.A., Hodge C.C., Hurtz D., Calafat A.M., Needham L.L., Brock J.W. Arch. Toxicol. 2003, 77:561-567.
14. Koch H.M., Bolt H.M., Preuss R., Angerer J. Arch. Toxicol. 2005, 79:367-376.
15. Silva M.J., Samandar E., Preau J.L., Needham L.L., Calafat A.M. Toxicology 2006, 219:22-32.
16. Koch H.M., Rossbach B., Drexler H., Angerer J. Environ. Res. 2003, 93:177-185.
17. Barr D.B., Silva M.J., Kato K., Reidy J.A., Malek N.A., Hurtz D., Sadowski M., Needham L.L., Calafat A.M. Environ. Health Perspect. 2003, 111:1148-1151.
18. Kato K., Silva M.J., Reidy J.A., Hurtz D., Malek N.A., Needham L.L., Nakazawa H., Barr D.B., Calafat A.M. Environ. Health Perspect. 2004, 112:327-330.
19. Silva M.J., Reidy J.A., Preau J.L., Samandar E., Needham L.L., Calafat A.M. Biomarkers 2006, 11:1-13.
20. Calafat A.M., Needham L.L., Silva M.J., Lambert G. Pediatrics 2004, 113:429-434.
21. Pan G., Hanaoka T., Yoshimura M., Zhang S., Wang P., Tsukino H., Inoue K., Nakazawa H., Tsugane S., Takahashi K. Environ. Health Perspect. 2006, 114:1643-1648.
22. Preuss R., Koch H., Angerer J. J. Chromatogr. B 2005, 816:269-280.
23. Kato K., Silva M.J., Needham L.L., Calafat A.M. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 814:355-360.
24. Silva M.J., Samandar E., Preau J.L., Reidy J.A., Needham L.L., Calafat A.M. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 860:106-112.
25. Blount B.C., Milgram K.E., Silva M.J., Malek N.A., Reidy J.A., Needham L.L., Brock J.W. Anal. Chem. 2000, 72:4127-4134.
26. Koch H.M., Gonzalez-Reche L.M., Angerer J. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 784:169-182.
27. Arndt P.A., Kumpel B.M. Am. J. Hematol. 2008, 83:657-667.
28. Giraud S., Robinson N., Mangin P., Saugy M. Forensic Sci. Int. 2008, 179:23-33.
29. Inoue K., Kawaguchi M., Yamanaka R., Highchi T., Ito R., Saito K., Nakazawa H. Clin. Chim. Acta 2005, 358:159-166.
30. Monfort N., Ventura R., Latorre A., Belalcazar V., López M., Segura J. Transfusion (Paris) 2010, 50:145-149.
31. Monfort N., Ventura R., Platen P., Hinrichs T., Brixius K., Schänzer W., Thevis M., Geyer H., Segura J. Transfusion (Paris) 2012, 52:647-657.
32. Monfort N., Ventura R., Platen P., Hinrichs T., Brixius K., Schänzer W., Thevis M., Geyer H., Segura J. Transfusion (Paris) 2012, 52(3):680-681.
33. Segura J., Monfort N., Ventura R. Drug Test. Anal. 2012, 10.1002/dta.405.
34. Solymos E., Guddat S., Geyer H., Flenker U., Thomas A., Segura J., Ventura R., Platen P., Schulte-Mattler M., Thevis M., Schänzer W. Anal. Bioanal. Chem. 2011, 401:517-528.
35. Solymos E., Guddat S., Geyer H., Flenker U., Thomas A., Segura J., Ventura R., Platen P., Schulte-Mattler M., Thevis M., Schänzer W. Anal. Bioanal. Chem. 2011, 401(2):579-580.
36. Solymos E., Guddat S., Geyer H., Thomas A., Thevis M., Schänzer W. Drug Test. Anal. 2011, 3:892-895.
37. Brooks T., Keevil C.W. Lett. Appl. Microbiol. 1997, 24:203-206.
38. World Anti-doping Agency, Technical Document TD2004EAAS. 2004. Version 1.0. Available at: (accessed September 2012). http://www.wada-ama.org/rtecontent/document/end_steroids_aug_04.pdf.
39. Solberg H.E. Comput. Methods Programs Biomed. 1995, 48(3):247-256.
40. Wittassek M., Wiesmuller G.A., Koch H.M., Eckard R., Dobler L., Muller J., Angerer J., Schluter Int C. J. Hyg. Environ. Health 2007, 210:319-333.
41. Frederiksen H., Jorgensen N., Andersson A.M. J. Anal. Toxicol. 2010, 34:400-410.
42. Colacino J.A., Robert H., Schecter A. Environ. Health Perspect. 2010, 118(7):998-1003.
43. Guo Y., Wu Q., Kannan K. Environ. Int. 2011, 37:893-898.
44. Frederiksen H., Aksglaede L., Sorensen K., Skakkebaek N.E., Juul A., Andersson A.M. Environ Res. 2011, 111:656-663.
45. Preau J.L., Wong L.Y., Silva M.J., Needham L.L., Calafat A.M. Environ. Health Perspect. 2010, 118:1748-1754.